PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31218550-3 2020 We previously showed that naringenin, a citrus flavonoid, suppressed macrophage infiltration into adipose tissue by inhibiting monocyte chemoattractant protein-1 (MCP-1) expression in the progression phase to high-fat diet (HFD)-induced obesity. naringenin 26-36 chemokine (C-C motif) ligand 2 Mus musculus 127-161 31218550-3 2020 We previously showed that naringenin, a citrus flavonoid, suppressed macrophage infiltration into adipose tissue by inhibiting monocyte chemoattractant protein-1 (MCP-1) expression in the progression phase to high-fat diet (HFD)-induced obesity. naringenin 26-36 chemokine (C-C motif) ligand 2 Mus musculus 163-168 31218550-6 2020 Naringenin tended to inhibit the HFD-induced expression of several chemokines, including MCP-1 and MCP-3, in adipose tissue. naringenin 0-10 chemokine (C-C motif) ligand 2 Mus musculus 89-94 25450363-4 2014 Naringenin suppressed monocyte chemoattractant protein-1 (MCP-1) in adipose tissue, and this effect was mediated in part through inhibition of c-Jun NH2-terminal kinase pathway. naringenin 0-10 chemokine (C-C motif) ligand 2 Mus musculus 22-56 25450363-4 2014 Naringenin suppressed monocyte chemoattractant protein-1 (MCP-1) in adipose tissue, and this effect was mediated in part through inhibition of c-Jun NH2-terminal kinase pathway. naringenin 0-10 chemokine (C-C motif) ligand 2 Mus musculus 58-63 25450363-5 2014 Naringenin also inhibited MCP-1 expression in adipocytes, macrophages, and a co-culture of adipocytes and macrophages. naringenin 0-10 chemokine (C-C motif) ligand 2 Mus musculus 26-31 23506745-4 2013 Pre-administration of naringenin significantly reduced the severity of colitis and resulted in down-regulation of pro-inflammatory mediators (inducible NO synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1), cyclo-oxygenase-2 (Cox2), TNF-alpha and IL-6 mRNA) in the colon mucosa. naringenin 22-32 chemokine (C-C motif) ligand 2 Mus musculus 216-250 23506745-4 2013 Pre-administration of naringenin significantly reduced the severity of colitis and resulted in down-regulation of pro-inflammatory mediators (inducible NO synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1), cyclo-oxygenase-2 (Cox2), TNF-alpha and IL-6 mRNA) in the colon mucosa. naringenin 22-32 chemokine (C-C motif) ligand 2 Mus musculus 252-257 22117528-4 2012 Naringenin treatments dose-dependently reduced renal tumor necrosis factor-alpha level and expression (P < 0.05) but only at 1 and 2% significantly decreased production and expression of interleukin (IL)-1beta, IL-6, and monocyte chemoattractant protein-1 (P < 0.05). naringenin 0-10 chemokine (C-C motif) ligand 2 Mus musculus 224-258 25745505-12 2015 Monocyte chemoattractant protein-1 (MCP1/Ccl2) and interleukin 6 (IL-6/Il6) mRNA expression levels were significantly lower in perigonadal adipose tissue of naringenin-supplemented mice. naringenin 157-167 chemokine (C-C motif) ligand 2 Mus musculus 0-34 25745505-12 2015 Monocyte chemoattractant protein-1 (MCP1/Ccl2) and interleukin 6 (IL-6/Il6) mRNA expression levels were significantly lower in perigonadal adipose tissue of naringenin-supplemented mice. naringenin 157-167 chemokine (C-C motif) ligand 2 Mus musculus 36-40 25745505-12 2015 Monocyte chemoattractant protein-1 (MCP1/Ccl2) and interleukin 6 (IL-6/Il6) mRNA expression levels were significantly lower in perigonadal adipose tissue of naringenin-supplemented mice. naringenin 157-167 chemokine (C-C motif) ligand 2 Mus musculus 41-45 22552813-6 2012 Naringenin also attenuated the production of pro-inflammatory cytokines and chemokines, including interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha) and monocyte chemoattractant protein-1 (MCP-1) by suppressing expression of mRNAs for these proteins. naringenin 0-10 chemokine (C-C motif) ligand 2 Mus musculus 196-242 22552813-6 2012 Naringenin also attenuated the production of pro-inflammatory cytokines and chemokines, including interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha) and monocyte chemoattractant protein-1 (MCP-1) by suppressing expression of mRNAs for these proteins. naringenin 0-10 chemokine (C-C motif) ligand 2 Mus musculus 244-249